Mesenchymal stem cells (MSCs) do not need soluble growth factors to change fate — the physical cues of their substrate are enough. Two mechanical inputs drive a RhoA/ROCK cytoskeletal-tension response that commits the cell:
Stiffness input: T_stiff(E) = E / (E + E_k), E_k ≈ 15 kPa (Engler et al. 2006)
Topography input: nanogrooves align focal adhesions and stress fibers along
the groove axis, elongating the cell (Yim et al. 2007);
nanopillars shrink the adhesive footprint onto pillar tops,
concentrating a few large, high-tension focal adhesions
(Dalby et al. 2007).
Fate rule (simplified composite of McBeath 2004 / Kilian 2010):
groove-aligned cell, elongation > 0.55 → neurogenic
tension > 0.66 → osteogenic
0.36 < tension ≤ 0.66 → myogenic
tension ≤ 0.36 → adipogenic
- Flat / Grooves / Pillars — switches the nanopatterned substrate geometry the colony sits on (top-down view).
- Feature spacing — pitch between grooves or pillars; narrower spacing means denser contact guidance (grooves) or a smaller adhesive footprint per cell (pillars).
- Feature height / depth — groove depth or pillar height; deeper/taller features amplify their topographic effect on adhesion and elongation, shown in the side cross-section panel.
- Substrate stiffness E — the classic Engler soft→stiff axis: ~0.5 kPa reads as brain-like (neurogenic bias), ~15 kPa as muscle-like (myogenic bias), ~40 kPa as bone-like (osteogenic bias), combined here with topography rather than replaced by it.
- The side cross-section draws contractile stress-fiber arrows around the hero cell — their length is the actual per-cell tension value, a direct read of the RhoA/ROCK contractility this model computes. Cell height (dome) drops and footprint widens as tension rises, matching the real flattened morphology of a high-tension cell.
- Drag the top-down view to pan across the colony; scroll/pinch to zoom.
Real-world relevance: this is the physical half of the article's "cellular reprogramming" — engineered nanotopography and substrate elasticity are used in regenerative scaffolds and wound dressings to steer resident or transplanted stem cells toward bone, muscle, nerve or fat lineages without drugs.